U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H29N7O4S
Molecular Weight 523.607
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AZELAPRAG

SMILES

COC1=CC=CC(OC)=C1N2C(NS(=O)(=O)[C@@H](C)[C@H](C)C3=NC=C(C)C=N3)=NN=C2C4=CN=CC(C)=C4

InChI

InChIKey=DOMQFIFVDIAOOT-ROUUACIJSA-N
InChI=1S/C25H29N7O4S/c1-15-10-19(14-26-11-15)24-29-30-25(32(24)22-20(35-5)8-7-9-21(22)36-6)31-37(33,34)18(4)17(3)23-27-12-16(2)13-28-23/h7-14,17-18H,1-6H3,(H,30,31)/t17-,18-/m0/s1

HIDE SMILES / InChI

Molecular Formula C25H29N7O4S
Molecular Weight 523.607
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:41:52 UTC 2023
Edited
by admin
on Sat Dec 16 11:41:52 UTC 2023
Record UNII
4B8REJ8ZGY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AZELAPRAG
INN  
Official Name English
2-PYRIMIDINEETHANESULFONAMIDE, N-(4-(2,6-DIMETHOXYPHENYL)-5-(5-METHYL-3-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL)-.ALPHA.,.BETA.,5-TRIMETHYL-, (.ALPHA.S,.BETA.R)-
Systematic Name English
azelaprag [INN]
Common Name English
Code System Code Type Description
CAS
2049980-18-7
Created by admin on Sat Dec 16 11:41:52 UTC 2023 , Edited by admin on Sat Dec 16 11:41:52 UTC 2023
PRIMARY
PUBCHEM
122702529
Created by admin on Sat Dec 16 11:41:52 UTC 2023 , Edited by admin on Sat Dec 16 11:41:52 UTC 2023
PRIMARY
NCI_THESAURUS
C166746
Created by admin on Sat Dec 16 11:41:52 UTC 2023 , Edited by admin on Sat Dec 16 11:41:52 UTC 2023
PRIMARY
INN
10870
Created by admin on Sat Dec 16 11:41:52 UTC 2023 , Edited by admin on Sat Dec 16 11:41:52 UTC 2023
PRIMARY
SMS_ID
100000183562
Created by admin on Sat Dec 16 11:41:52 UTC 2023 , Edited by admin on Sat Dec 16 11:41:52 UTC 2023
PRIMARY
FDA UNII
4B8REJ8ZGY
Created by admin on Sat Dec 16 11:41:52 UTC 2023 , Edited by admin on Sat Dec 16 11:41:52 UTC 2023
PRIMARY
Related Record Type Details
TRANSPORTER -> SUBSTRATE
METABOLIC ENZYME -> INDUCER
Determined by increases in CYP3A4 messenger RNA levels in primary human hepatocytes.
BINDER->LIGAND
BINDING
TARGET -> INHIBITOR
METABOLIC ENZYME -> SUBSTRATE
TRANSPORTER -> SUBSTRATE
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC